Author

Rola Raychouni

Eugene Applebaum College of Pharmacy and Health Sciences

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Angel Schilke· 1 shared Defeng Cai· 1 shared Efren Heredia· 1 shared Ernesto Abel‐SantosiD· 1 shared Huy Nguyen· 1 shared S T Bahade A S Lanje and S J Sharma S T Bahade A S Lanje and S J SharmaiD· 1 shared Steven M. FirestineiD· 1 shared W.T. LiuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Angel Schilke

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Novel bile salt analogs reduce lipid accumulation in liver cells with potential to treat both metabolic dysfunction-associated steatotic liver disease and Clostridioides difficile infection

Defeng Cai, Huy Nguyen, Yang Zhang, S T Bahade A S Lanje and S J Sharma S T Bahade A S Lanje and S J Sharma, Angel Schilke, Rola Raychouni, Efren Heredia, Ernesto Abel‐Santos, Steven M. Firestine, W.T. Liu

The paper screens bile salt analogs to identify compounds that reduce lipid accumulation in liver cells and inhibit C. difficile spore germination, offering potential dual therapy for MASLD and CDI.

bioRxiv · Jun 16, 2026 · PreprintPharmacology & Toxicology